NewEdge Advisors’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
NewEdge Advisors's NUVB Position: Q3 2026 in Review
NewEdge Advisors increased its Nuvation Bio (NUVB) stake by 26% in Q3 2026, buying an estimated $1.98M and bringing the position to 1,546,883 shares worth $8.66M. The position accounts for 0.03% of the portfolio, ranked #552.
NewEdge Advisors first reported a position in NUVB in Q4 2025 and has held it in 4 quarters since. 258 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.
- NewEdge Advisors held 1,546,883 shares of Nuvation Bio worth $8.66M as of Q3 2026.
- NewEdge Advisors bought 315,150 Nuvation Bio shares in Q3 2026, an estimated $1.98M.
- Nuvation Bio made up 0.03% of NewEdge Advisors's portfolio in Q3 2026, its #552 holding.
- NewEdge Advisors first reported a position in Nuvation Bio in Q4 2025 and has held it in 4 quarters since.
- 258 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.
Based on NewEdge Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.